Table of Contents Table of Contents
Previous Page  1008 1030 Next Page
Information
Show Menu
Previous Page 1008 1030 Next Page
Page Background

patients, TTh alone could be considered in milder forms of

ED, whereas in the more severe forms the add-on of other

treatments, such as a PDE5i, might be appropriate.

TTh was less effective in improving EFD-score in patients

with obesity and diabetes. This finding is not surprising as it

is consistent with the reduced efficacy seen for all available

treatments for ED in patients with diabetes. This is likely

due to the presence of multiple diabetes-associated

complications, such as peripheral neuropathy and vasculo-

pathy, including macroangiopathy, microangiopathy, and

[(Fig._6)TD$FIG]

Overall erectile function domain

TT < 12 nM

TT < 8 nM

Libido domain

Intercourse satisfaction domain

Orgasmdomain

Paduch et al 2015 excluded

Overallsatisfaction

TotalIIEF-15 score

1806

0.001

2.29

1.30

1.80

774

0.001

2.03

0.9

1.47

1438

0.001

4.03

1.86

2.95

1269

0.001

0.28

0.12

0.20

1269

0.001

1.37

0.78

1.07

1300

0.010

0.48

0.06

0.27

1224

0.001

0.71

0.22

0.47

1269

0.001

0.46

0.20

0.33

607

0.001

5.20

2.18

3.60

-3.00

-2.00

-1.00

0.00

1.00

2.00

3.00

4.00

5.00

6.00

7.00

IIEF domains

IIEF score mean differences

A

B

–3 –2 –1 0 1 2 3 4 5 6 7

Diff. in mean LL, 95% CI UL, 95% CI

p

N

Placebo

TTh

-3.00

-2.00

-1.00

0.00

1.00

2.00

3.00

4.00

5.00

6.00

7.00

IIEF domains

IIEF score mean differences

Diff. in mean LL, 95% CI UL, 95% CI

p

N

Overall erectile function domain

TT < 12 nM

TT < 8 nM

Libido domain

Intercourse satisfaction domain

Orgasmdomain

Paduch et al2015 excluded

Overallsatisfaction

TotalIIEF-15 score

1806

0.001

3.22

1.41

2.31

774

0.001

2.03

0.9

1.47

1438

0.001

4.03

1.86

2.95

1269

0.001

0.54

0.12

0.33

1269

0.001

1.44

0.77

1.10

1300

0.030

1.21

0.05

0.63

1224

0.010

1.55

0.23

0.89

1269

0.010

0.64

0.08

0.36

607

0.001

9.20

1.72

5.46

Placebo

TTh

–3 –2 –1 0 1 2 3 4 5 6 7

Fig. 6 – Mean (with 95% confidence interval [CI]) of testosterone treatment (TTh) versus placebo on International Index of Erectile Function (IIEF)

domains as derived by applying (A) fixed or (B) random models.

Diff = differences; LL = lower limits; TT = total testosterone; UP = upper limits.

E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 1 0 0 0 – 1 0 1 1

1008